跳至主要内容
临床试验/NCT02500368
NCT02500368已完成不适用

A Dispensing Clinical Trial of a Study Test Silicone Hydrogel Lens Against Control Lens Over 1 Week

Coopervision, Inc.1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2015年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
41
试验地点
1
主要终点
Comfort

研究概览

简要总结

This is a 1-week dispensing, double-masked, randomized, bilateral study comparing the test lens against the control lens.

详细描述

The order of lens wear (test lens first, control lens second or control lens first, test lens second) will be selected according to a randomization table.

Both test and control lenses will be used in a daily wear modality for 1 week. It is anticipated that this study will involve following visits: Baseline (screening and dispense of 1st study pair of lenses, visit combined), 1-week visit (follow-up of the 1st study pair of lenses and dispense the 2nd study pair of lenses) and 2-week visit (1 week follow-up of the 2nd study pair of lenses).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
17 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •A person is eligible for inclusion in the study if he/she:
  • •Is at least 17 years of age and has full legal capacity to volunteer
  • •Has read and understood the information consent letter
  • •Is willing and able to follow instructions and maintain the appointment schedule
  • •Is correctable to a visual acuity of 20/30 or better (in each eye) with their habitual correction and the assigned study lenses
  • •Is an adapted soft contact lens wearer (For the purpose of this study: Current lens wear at least 3 days per week, 8 hours each day.)

排除标准

  • •A person will be excluded from the study if he/she:
  • •Is participating in any concurrent clinical or research study
  • •Has any known active* ocular disease and/or infection
  • •Has a systemic condition that in the opinion of the investigator may affect a study outcome variable**
  • •Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable
  • •Has known sensitivity to the diagnostic pharmaceuticals to be used in the study
  • •Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit).
  • •Is aphakic
  • •Has undergone corneal refractive surgery.
  • •For the purposes of this study, active* ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active. Participants will be excluded with significant slit lamp findings (e.g. infiltrates or other slit lamp findings Grade 3 or above: corneal edema, tarsal abnormalities, and conjunctival injection) or active ocular disease (e.g. glaucoma, history of recurrent corneal erosions, and intraocular infection or inflammation of an allergic, bacterial, or viral etiology)
  • •For the purposes of this study, participants will be excluded**, if currently taking medication, such as oral antihistamines, antihistamine eye drops, oral and ophthalmic beta-adrenergic blockers (e.g. Propanolol, Timolol), anticholinergics, oral steroids and any prescribed or over-the-counter eye medication, except artificial tears or eye lubricants

研究组 & 干预措施

silicone hydrogel lens (test)

Experimental

Participants were randomized to wear silicone hydrogel lens (test) for 1 week during the cross over study.

干预措施: silicone hydrogel lens (test) (Device)

enfilcon A lens (control)

Active Comparator

Participants were randomized to wear enfilcon A lens (control) for 1 week during the cross over study.

干预措施: enfilcon A lens (control) (Device)

结局指标

主要结局

Comfort

时间窗: Baseline and 1 week

Subjective ratings scale (0-100) assessed: 0=Cannot be worn, causes pain, 20=Frequently irritating, 40=Occasionally irritating, 60=Occasionally noticable but not irritating, 80=Rarely noticeable, 100=Cannot be felt ever. Time points for comfort: lens dispense at baseline, lens insertion at 1 week, and overall at 1 week.

Dryness

时间窗: Baseline and 1 week

Subjective ratings scale (0-100): 0=Cannot be worn, extremely dry, 20=Frequently Irritating, 40=Occasionally irritating, 60=Occasionally noticeable but not irritating, 80=Rarely noticeable, 100=No dryness experienced at any time. Time points for dryness: lens dispense at baseline, lens insertion at 1 week, and overall at 1 week.

次要结局

  • Lens Wettability(Baseline and 1 week)
  • Lens Tightness(Baseline and 1 week)
  • Ease of Lens Removal(1 week)
  • Overall Lens Fit(Baseline and 1 week)
  • Lens Problems(Baseline and 1 week)
  • Post-blink Movement(Baseline and 1 week)
  • Bulbar Hyperemia(Baseline and 1 week)
  • Visual Quality(Baseline and 1 week)
  • Corneal Dehydration Staining(1 week)
  • Lens Deposition(Baseline and 1 week)
  • Lens Centration(1 week)
  • Ease of Lens Insertion(Baseline and 1 week)
  • Corneal Staining (Extent)(Baseline and 1 week)
  • Conjunctival Indentation(Baseline and 1 week.)
  • Conjunctival Staining(Baseline and 1 week)
  • Surface Appearance(1 week)
  • High Contrast Acuity at High Room Illumination(Baseline and 1 week)
  • Limbal Hyperemia(Baseline and 1 week)
  • Surface Appearance(Baseline)
  • Lens Centration(Baseline)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验